Monitoring of serum squamous cell carcinoma antigen levels in invasive cervical cancer: is it cost-effective?
Posttreatment SCC monitoring is not cost-effective in the absence of curative treatment for distant spread of disease.
Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classes. Prescribing additional antihypertensive drug classes and lifestyle modification may improve blood pressure control in this population of individuals at increased cardiovascular risk.